Plans have been unveiled for the latest proton beam therapy centre in the UK.
Proton Partners International has announced proposals to build a new £35m cancer treatment centre in Liverpool.
The facility will be built in the new £1billion Paddington Village, part of Liverpool’s Knowledge Quarter (KQ).
This will be one of four centres in total built by Proton Partners International in the UK and will make the company the world’s -argest developer of proton beam therapy clinics.
The company is currently building three other UK cancer centres in Newport, Northumberland, and Reading, and is considering further sites across the country.
The oncology centre, which will be known as The Rutherford Cancer Centre North West, will offer radiotherapy, chemotherapy, and imaging from 2018, and proton beam therapy will be available in 2019.
Mike Moran, chief executive officer of Proton Partners International, said: “Not only will we be bringing the top cancer technology to the North West, but we will be located at heart of what will be a world-class destination for science, innovation, education, and technology.
“This investment will not only enhance the level of cancer treatment available to patients, but will also bring skilled jobs to the area.”
It is expected The Rutherford Cancer Centres will each be able to treat up to 500 patients a year and treatment will be available to medically-insured private patients, self-paying patients, and patients referred by the NHS.
Proton Partners International is also building a genomics research centre at the Life Sciences Accelerator building in Liverpool, which will be the first part of a health campus set to surround the £335m new Royal Liverpool Hospital.
The genomics programme will support Proton Partners International’s broader research work with the University of Liverpool’s physics department.
Proton beam therapy is the very-latest cancer treatment method, previously unavailable in this country
